In vitro induction of human immunodeficiency virus type 1 variants resistant to 2'-beta-Fluoro-2',3'-dideoxyadenosine.

MLA

Tanaka, M., et al. “In Vitro Induction of Human Immunodeficiency Virus Type 1 Variants Resistant to 2’-Beta-Fluoro-2’,3’-Dideoxyadenosine.” Antimicrobial Agents and Chemotherapy, vol. 41, no. 6, June 1997, pp. 1313–18. EBSCOhost, https://doi.org/10.1128/AAC.41.6.1313.

APA

Tanaka, M., Srinivas, R. V., Ueno, T., Kavlick, M. F., Hui, F. K., Fridland, A., Driscoll, J. S., & Mitsuya, H. (1997). In vitro induction of human immunodeficiency virus type 1 variants resistant to 2’-beta-Fluoro-2’,3’-dideoxyadenosine. Antimicrobial Agents and Chemotherapy, 41(6), 1313–1318. https://doi.org/10.1128/AAC.41.6.1313

Chicago

Tanaka, M, R V Srinivas, T Ueno, M F Kavlick, F K Hui, A Fridland, J S Driscoll, and H Mitsuya. 1997. “In Vitro Induction of Human Immunodeficiency Virus Type 1 Variants Resistant to 2’-Beta-Fluoro-2’,3’-Dideoxyadenosine.” Antimicrobial Agents and Chemotherapy 41 (6): 1313–18. doi:10.1128/AAC.41.6.1313.